EZZ Life Science Holdings (ASX: EZZ) is an Australian-listed company in the Healthcare sector with a market capitalisation of $24.0M and the 1237th-largest security on the ASX by market capitalisation. The EZZ share price is $0.51, up 0.99% today and down 77.84% over the past 12 months. Shares have traded between $0.50 and $3.38 over the past 52 weeks. EZZ pays a trailing dividend yield of 1.35%. In its most recent reported period (ending 31 Dec 2025), EZZ Life Science Holdings reported revenue of $24.8M and a net loss of $641,298.
About EZZ Life Science Holdings Limited
EZZ Life Science Holdings Limited, an Australian company, specializes in offering a range of skincare and consumer health products, with its market presence extending across Australia, New Zealand, Mainland China, and other international territories. The company's operations are divided into two distinct segments: 'Brought in Lines' and 'Company Owned products.' EZZ is actively involved in the wholesale supply of its EAORON-branded skincare portfolio, distributing it to pharmacies, major supermarkets, specialist retailers, and general grocery stores. Furthermore, the company designs, develops, manufactures, and markets a comprehensive selection of consumer health products under its own EZZ brand. This extensive offering includes vitamins, dietary supplements, sports nutrition, weight management and wellbeing solutions, traditional herbal remedies, and paediatric lines. These EZZ-branded items are sold directly to consumers via its e-commerce platforms and various retail stores, notably Tmall Global. Founded in 2015, EZZ Life Science Holdings Limited maintains its corporate headquarters in Silverwater, Australia.
